Ketamine shows promise for stubborn bipolar depression in new trial
NCT ID NCT05004896
Summary
This study tested whether repeated low-dose ketamine infusions could help people with treatment-resistant bipolar depression. 71 participants who hadn't responded to standard medications received either ketamine or a sedative placebo over two weeks. Researchers measured changes in depression, suicidal thoughts, and quality of life to see if ketamine was safe and effective for this condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIPOLAR DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ontario Shores Centre for Mental Health Sciences
Whitby, Ontario, L1N 5S9, Canada
-
Toronto General Hospital
Toronto, Ontario, M5G 2C4, Canada
-
Toronto Western Hospital
Toronto, Ontario, M5T 2S8, Canada
Conditions
Explore the condition pages connected to this study.